Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct;11(10):e780-e791.
doi: 10.1016/S2352-3026(24)00209-6. Epub 2024 Sep 20.

Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation

Affiliations
Review

Sexual health-related psychological and emotional life after allogeneic haematopoietic stem-cell transplantation

Tamim Alsuliman et al. Lancet Haematol. 2024 Oct.

Abstract

Sexual health is important for the quality of life of patients who have received haematopoietic stem-cell transplantation (HSCT). Sexual dysfunction and couple dissatisfaction can seriously affect a patient's recovery and treatment process. However, this aspect of post-transplantation recovery is still usually neglected in clinical practice. In this Series paper, we aim to elucidate the emotional and psychosocial factors affecting the sexual function in these patients, with a special focus on the partner's role and the psychological consequences of some adverse effects of HSCT. Moreover, we provide an overview of the management approaches and assessment tools of psychological issues associated with sexual dysfunction reported in the literature. These tools can help clinicians in this field to plan essential lifestyle and clinical interventions to help their patients. In conclusion, screening for psychological issues is indispensable when approaching sexual dysfunction in patients with HSCT. Health-care teams in transplantation units should be trained to discuss this aspect of recovery and provide the required treatment and follow-up plan.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests LA declares a PhD scholarship by PAUSE (Programme d'aide à l'Accueil en Urgence des Scientifiques en Exil). YC has received honoraria from Abbvie, Amgen, Astra-Zeneca, Bristol Myers Squibb, Gilead, Incyte, Jazz, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Servier, and Takeda; and travel support from Abbvie, Amgen, Astra-Zeneca, Bristol Myers Squibb, Gilead, Incyte, Jazz, Merck Sharp & Dohme, Novartis, Pfizer, Roche, and Sanofi. AL is an unpaid member of the European Society for Blood and Marrow Transplantation (EBMT) Patient Advocacy Committee (board member). HS declares grants or contracts, paid to her institution, from Novartis and the Belgian Hematological Society; consulting fees, paid to her institution, from Incyte, Janssen, Novartis, and Sanofi; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events, paid to her institution, from Novartis and the Belgian Hematological Society; support for attending meetings and travel, paid to her institution, from Pfizer, Gilead, EBMT, and Center for International Bone Marrow Transplantation Research; participation on a Data Safety Monitoring Board or Advisory Board for Hôpital Saint-Louis, Paris, France (unpaid); and leadership or fiduciary roles for EBMT (unpaid), the Center for International Bone Marrow Transplantation Research (unpaid voluntary work), and Belgian Hematological Society (unpaid). TA declares consulting fees from Biotest and Amgen; honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from biotest; receiving meeting or travel support from Biotest, Sandoz, Novartis, Astellas Pharma, and Viatris; and leadership or fiduciary roles for the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (unpaid, responsible for practice harmonisation group). MM declares grants or contracts (outside of the present Series papers) from Sanofi, Novartis, and Janssen; consulting fees from Adaptive Biotechnologies, Amgen, Astellas, Bristol Myers Squibb, GlaxoSmithKline, Janssen, Jazz, Novartis, Pfizer, Sanofi, Stemline, and Takeda; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Adaptive Biotechnologies, Amgen, Astellas, Bristol Myers Squibb, GlaxoSmithKline, Janssen, Jazz, Novartis, Pfizer, Sanofi, Stemline, Takeda, and MaaT; participation on a Data Safety Monitoring Board or Advisory Board for Janssen; and leadership or fiduciary role for EBMT and the International Academy for Clinical Hematology. FM declares payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Therakos–Mallinckrodt, Sanofi, Bristol Myers Squibb, Merck Sharp & Dohme, Astrazeneca, Jazz Pharmaceuticals, Gilead, and Novartis. ZP declares consulting fees from Sanofi; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Therakos, Sanofi, Pfizer, and Astrazeneca; and was the transplant complications working party chair for EBMT. All other authors declare no competing interests.

Similar articles

Cited by

MeSH terms

LinkOut - more resources